Displaying results 1 - 12 of 21
Public Health and Advocacy
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues
View
General Hepatology
EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio
View
Viral Hepatitis
EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF
View
Public Health and Advocacy
EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - EN

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - EN

PDF
View
Public Health and Advocacy
EASL Policy Statement on Liver Cancer Screening

EASL Policy Statement on Liver Cancer Screening

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - EN

EASL Policy Statement on Hepatitis C Elimination - EN

PDF
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
COVID-19 and the liver
Patient Association COVID-19 Toolkit final

Patient Association COVID-19 Toolkit final

PDF
View
COVID-19 and the liver
Care of Patients with Liver Diseases during the COVID-19 Pandemic

Care of Patients with Liver Diseases during the COVID-19 Pandemic

Slide Decks
View
General Hepatology
EASL Studio S3 E6: How to improve end-of-life care in liver disease?

EASL Studio S3 E6: How to improve end-of-life care in liver disease?

EASL Studio
View